Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain–Barré syndrome after Campylobacter jejuni enteritis
- 1 May 1999
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 96 (2) , 245-250
- https://doi.org/10.1016/s0165-5728(99)00040-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 20 references indexed in Scilit:
- Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor functionJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain–Barré and Fisher's syndromesJournal of Neuroimmunology, 1998
- Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndromeAnnals of Neurology, 1996
- Anti‐GD1a ganglioside antibodies in peripheral motor syndromesAnnals of Neurology, 1996
- Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infectionAnnals of Neurology, 1995
- N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndromeAnnals of Neurology, 1994
- Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodiesMuscle & Nerve, 1992
- Anti-GM1 IgA antibodies in Guillain-Barré syndromeJournal of Neuroimmunology, 1992
- Molecular heterogeneity of human IgA antibodies during an immune responseClinical and Experimental Immunology, 1992
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990